Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Jan 1.
Published in final edited form as: Drug Alcohol Depend. 2024 Nov 17;266:112499. doi: 10.1016/j.drugalcdep.2024.112499

Correlates of nicotine patch adherence in daily life

Lindsey N Potter 1,2,†, Dusti R Jones 1,2,†, David B Braudt 1, Inbal Nahum-Shani 3,4, Cho Y Lam 1,2, Christopher Fagundes 5, David W Wetter 1,2
PMCID: PMC12097193  NIHMSID: NIHMS2038040  PMID: 39577027

Abstract

Background:

African Americans who smoke are disproportionately affected by the health consequences of smoking. Nicotine replacement therapy (NRT) is effective for helping people successfully quit, yet there are well-documented issues with nicotine patch adherence. This study aimed to examine the real-time associations of risk factors for patch non-adherence [lapse, motivation, self-efficacy, urge, cigarette availability] with patch adherence in a sample of African Americans who smoke and are attempting to quit.

Methods:

Participants were 239 African American adults, 50% female, and ages 18–74. Ecological momentary assessment was used to assess patch use and risk factors. Multilevel modeling for binary outcomes was used to test concurrent and lagged associations between risk factors and patch use.

Results:

Lapse at a previous assessment (OR=0.61, 95% CI: 0.42, 0.88), and urge (OR=0.77, 95% CI: 0.66, 0.89) and cigarette availability (OR=0.84, 95% CI: 0.71, 0.99) at concurrent assessments were associated with lower likelihood of patch use. Concurrent motivation (OR=1.28, 95% CI: 1.05, 1.55) and self-efficacy (OR=1.31, 95% CI: 1.06, 1.62) were associated with greater likelihood of patch use. There were no significant lagged associations between motivation, self-efficacy, urge, or cigarette availability with patch use.

Discussion:

It is critical to examine correlates of non-adherence among African Americans who smoke because they are less likely to quit and are disproportionately impacted by the health consequences of tobacco use. The results suggest that interventions might focus on promoting patch adherence at certain times (e.g., when cigarettes are available) and/or leveraging the benefits of protective factors (e.g., motivation and self-efficacy).

Keywords: Nicotine patch adherence, ecological momentary assessment, tobacco cessation, mHealth, health inequities

1.1. Introduction

Tobacco use is the leading cause of preventable death and disease and is responsible for nearly one in five deaths in the United States (Cornelius et al., 2023; Danaei et al., 2009; Mokdad et al., 2004). Although overall tobacco smoking rates have declined (Cornelius et al., 2022; Creamer et al., 2019), there are inequities in tobacco cessation, with individuals who identify as African American being less likely to successfully quit than those who identify as White (Kulak et al., 2016; Stahre et al., 2010; VanFrank et al., 2024). Notably, racial inequities in tobacco cessation cannot be attributed to differences in the desire to quit. Compared to other racial and ethnic groups, a higher percentage of African Americans who smoke report having a desire to quit (CDC, 2022) and more African Americans who smoke report making a quit attempt in the past year compared to White and Latino people who smoke (Stahre et al., 2010; VanFrank et al., 2024). Unfortunately, despite smoking fewer cigarettes per day than White smokers (Haiman et al., 2006; Holford et al., 2016), African Americans who smoke have lower cessation success rates (Kulak et al., 2016; Stahre et al., 2010; VanFrank et al., 2024). Moreover, they are disproportionately affected by the negative health consequences of smoking (e.g., elevated risk of lung cancer compared to White smokers (Haiman et al., 2006; Sakuma et al., 2016; Siegel et al., 2022). Models of social determinants of health highlight that historically marginalized populations are disproportionately exposed to environments that are more conducive to smoking (Adler & Ostrove, 1999; Crittenden et al., 2007), including fewer smoking restrictions, more exposure to others’ smoking, greater cigarette availability, and a higher density of tobacco outlets. They may also experience higher stress and discrimination and have more limited resources that could alleviate those factors (e.g., social trust, social support, neighborhood cohesion; (Businelle et al., 2010; Cambron et al., 2019).

Nicotine replacement therapy (NRT) is an effective method for helping individuals quit smoking and can double the rate of long-term cessation (Hughes et al., 2003; West et al., 2018), and studies suggest that individuals using the patch (vs. placebo or non-NRT control) are more than 60% more likely to quit (Hartmann-Boyce et al., 2018). However, there are significant issues with adherence to NRT. Previous research has found that White smokers attempting to quit are more adherent to patches and gum compared to other racial/ethnic groups (Schlam et al., 2018), yet limited research has examined the real-time correlates of adherence to the nicotine patch among non-White smokers. This study seeks to fill that gap by examining the real-time correlates of nicotine patch adherence among African Americans who smoke during a cessation attempt.

Nicotine patches are one of the most used NRT modalities among smokers who have successfully quit or are attempting to quit. Nicotine patches were developed to improve compliance issues with smoking cessation therapies (Shiffman et al., 2008) and offer “relief levels” of nicotine through steady transdermal release in order to prevent severe withdrawal symptoms associated with the absence of nicotine (Fagerström et al., 1993). Nicotine patches have been found to attenuate urges to smoke (Ferguson & Shiffman, 2009; Ferguson et al., 2006), and have been linked to higher self-efficacy and motivation among smokers attempting to quit (Collins et al., 2013; Mersha et al., 2020; Stanton et al., 2009). Studies using ecological momentary assessment (EMA) have shown that patches can attenuate withdrawal and urge severity in daily life, and reduce the daily risk of lapsing (Ferguson et al., 2006). A recent study found that, compared with a placebo or non-NRT control group, smokers who use the nicotine patch had 1.64 times greater odds of successfully quitting (Hartmann-Boyce et al., 2018).

Although studies show that adherence to the nicotine patch may be higher than adherence to other forms of NRT (Yingst et al., 2015), smoking cessation trials and large primary care studies show notable adherence issues. One study found that over 31% of individuals missed at least one day of patch wear in the first three weeks of treatment (Shiffman et al., 2008), and another found that individuals used the patch on only about 66% of days over the first 6 weeks of their quit attempt (Schlam et al., 2018). Thus, given that individuals who are more adherent to the patch demonstrate a greater likelihood of achieving abstinence (Hartmann-Boyce et al., 2018; Shiffman et al., 2008), studies examining the correlates of patch adherence may inform interventions to improve adherence and long-term cessation outcomes. This may be especially important for African Americans who smoke, as they tend to have greater difficulty quitting (Kulak et al., 2016; Stahre et al., 2010), are less likely to use NRT (Fu et al., 2008; Trinidad et al., 2011), and suffer a disproportionate burden of smoking-related health outcomes (Haiman et al., 2006; Sakuma et al., 2016). African Americans may have lower cessation success due to a number of factors, including social determinants of health such as lower socioeconomic status (Okuyemi et al., 2010), chronic exposure to racism or stress associated with racism or socioeconomic status, or reduced access to culturally relevant tobacco cessation interventions or NRT education (Carpenter et al., 2011; Nollen et al., 2007), thus understanding factors that may impede adherence to cessation aids is critical to improve cessation inequities in this population.

Recent studies found that forgetfulness, a desire to try to quit without using patches, side effects, and fear of becoming dependent on patches were associated with non-adherence (Kushnir et al., 2017; Wiggers et al., 2006; Yingst et al., 2015). Further, in line with social cognitive models of relapse prevention (Brandon et al., 2007; Witkiewitz & Marlatt, 2004), factors such as motivation or urge may also be related to patch adherence. For example, one study found that higher levels of motivation were associated with a higher number of days of patch use (Alterman et al., 1999). Similarly, greater baseline motivation to quit is linked with greater adherence to daily patch use (Kim et al., 2019). Stress-elicited urge to smoke has been linked to higher probability of daily patch use (Kim et al., 2019), and relapse has been linked to NRT non-adherence (Burns & Levinson, 2008; Pacek et al., 2018; Schlam et al., 2018). One study found that individuals who reported at baseline that they were exposed to other smokers for more than half their day showed a higher probability of daily patch use (Kim et al., 2019), suggesting that having cigarettes available may increase adherence. A recent EMA study found that daily use of patches and gum was significantly associated with a lower likelihood of lapse within the same day and on the following day (Hébert et al., 2021). This study also examined reasons for patch non-adherence and found that, in addition to reasons commonly cited in the literature (e.g., forgetfulness, side effects, perceptions that the patch is ineffective), the most cited reason for patch non-adherence was “other.” This suggests that more research is needed to understand the real-time correlates of nicotine patch use during a smoking quit attempt (Hébert et al., 2021).

The available evidence highlights that several factors (e.g., motivation, urge to smoke) may influence adherence to the nicotine patch, yet research on the dynamic relationship between theoretically- and empirically-driven risk factors and patch adherence is limited, particularly among African Americans who smoke. Social cognitive models of addiction and relapse suggest that motivation, self-efficacy, urge, and cigarette availability have a prominent influence on substance use behaviors (Brandon et al., 2007; Witkiewitz & Marlatt, 2004), and further that key factors associated with behavior change (e.g., motivation) can fluctuate depending on time and context (Brandon et al., 2007; Witkiewitz & Marlatt, 2004). Thus it seems likely that these cognitive processes would also influence patch use.

The current study aimed to examine the real-time, real-world associations of empirically- and theoretically-driven risk factors (lapse, motivation, self-efficacy, urge, cigarette availability) with adherence to nicotine patch use in a sample of African Americans who smoke who were attempting to quit. Based on extant literature, we hypothesized a positive within-person association between motivation, urge, self-efficacy, and cigarette availability with nicotine patch use, and a negative within-person association between lapse and nicotine patch use.

1.2. Methods

1.2.1. Participants and Procedures

Data for the current study were collected in a longitudinal study examining the influence of contextual and environmental factors, demographics and social history, biobehavioral/psychosocial predispositions, and acute momentary precipitants on smoking lapse and abstinence among African Americans who smoke and are attempting to quit. Participants were recruited between 2017 and 2019 from the Houston, TX area using radio, print media (e.g., newspapers), and community outreach. Participants were at least 18 years of age, smoked an average of 3 or more cigarettes per day, had an expired carbon monoxide level of 6 PPM or greater, and self-reported as African American. Eligible participants were motivated to quit smoking within the next 30 days, had a valid home address, a functioning telephone number, and could read, write, and speak English, with at least marginal health literacy. Exclusion criteria included contraindication for the nicotine patch, use of recreational drugs in the past 30 days, current or previous enrollment (in the last 90 days) in a smoking cessation program, having another household member enrolled in the study, current use of tobacco cessation medications, and pregnancy or lactation. Participants attended several study visits, during which they filled out a series of questionnaires and trained Research Assistants delivered brief quitting advice. Research Assistants were trained by a Licensed Clinical Psychologist to follow a protocol adapted from the Treating Tobacco Use and Dependence: Clinical Practice Guideline (Fiore et al., 2008) and the National Cancer Institute’s Clearing the Air booklet. (Fiore et al., 2008). Participants were offered 6-weeks of nicotine patch therapy during study visits, with patches being distributed during visits 1, 2 and 4 (patch regimen was based on the self-reported number of cigarettes smoked per day at baseline). Participants were instructed by trained study staff to start using the patch use on their pre-specified quit date and received training about where on their body to wear the patch, how long to wear the patch each day/when to change it, and when to switch to a different patch dosage. Participants were given study staff contact information, which they could call at any time if they had questions or concerns about wearing the patch. Participants had the right to choose not to wear the patch. Participants were compensated $30 each for completing visits 1–3, $80 for completing visit 4 + payments for completed EMAs ($1.25 if they wore the wrist sensors for at least 60% of the time since the prior EMA, $.50 otherwise), $10 for completing a call at week 12 post-quit, and $60 for completing the 6-month follow up visit (up to $450). All procedures were approved by the Rice University IRB. Details about study procedures have been published elsewhere (Potter et al., 2023).

EMAs were collected using a pre-programmed smartphone that participants carried with them for 14 contiguous days (4 days pre-quit through 10 days post-quit). Participants were also asked to wear a sensor on each wrist during the 14-day period during normal waking hours. Sensors were designed to detect physiological indicators of stress and movements indicative of smoking (Ertin et al., 2011; Nakajima et al., 2020; Saleheen et al., 2015). Each day was divided into four 4-hour blocks and one EMA was scheduled to be delivered at semi -random intervals during each of the four blocks (i.e., approximately once every four hours). Random EMAs captured the real-time, real-world dynamics of smoking behaviors, mood, urges, and other cognitive, interpersonal, and contextual factors. Participants could receive additional EMAs based on data from sensors, however, because these did not assess all constructs of interest, only information about lapse and patch use from these assessments were used in the analytic data. In this way, we used information from random and sensor-triggered EMAs to capture whether someone reported consistently wearing the patch or lapsed between random EMAs. The analytic data was coded such that participants received a “1” if they reported consistently wearing the patch in all assessments (i.e., in a sensor-triggered EMA) that occurred between two random EMAs, and a “0” if they wore the patch inconsistently or not at all. Similarly for the lapse, if participants reported a lapse at any assessment, they received a “1” to indicate a lapse during the interval between two random EMAs.

1.2.2. Study Visit Measures (Time Invariant)

Participants provided demographic (e.g., age in years, gender, partner status, education) and dependence (cigarettes per day) information at baseline. Education, gender, and partner status were dummy coded (education: 0 = no college degree, 1 = college degree; gender: 0 = male, 1 = female; partner status: 0 = single, 1 = married/cohabitating). Participants also provided psychosocial variables, including measures for depression (Patient Health Questionnaire 9) and anxiety (Generalized Anxiety Disorder 7). Finally, participants indicated how many days in the past 30 days that they used e-cigarettes.

1.2.3. EMA Measures (Time-Varying)

Nicotine patch use was assessed at random, smoking, and stress EMAs using one item, “Are you wearing the patch right now?” (Yes/No). Smoking and stress EMAs assessed between random EMAs were recoded as described above.

Smoking lapse was assessed using random, smoking, and stress EMAs with the item, “Since the last assessment, have you smoked any cigarettes?” (Yes/No). A single “lapse” variable was created to indicate whether a participant smoked one or more times in the interval between two random EMAs (1= lapse, 0= no lapse).

Urge was assessed using one item at each random EMA, “I have an urge to smoke”. Participants responded on a scale of 1 (Strongly Disagree) to 5 (Strongly Agree).

Motivation was assessed at each random EMA using one item, “I am very motivated to be abstinent from cigarettes”. Participants responded on a scale of 1 (Strongly Disagree) to 5 (Strongly Agree).

Self-efficacy was assessed at each random EMA using one item, “I am confident in my ability to be abstinent from cigarettes”. Participants responded on a scale of 1 (Strongly Disagree) to 5 (Strongly Agree).

Cigarette availability was assessed at each random EMA using one item, “Cigarettes are available to me”. Participants responded on a scale of 1 (Not at all) to 5 (Easily).

1.2.4. Analytic Plan

Generalized linear mixed models were estimated using SAS 9.4 and the PROC GLIMMIX command with binary outcomes and residual pseudo-likelihood estimation, which are recommended for data that has a nested structure. Momentary predictors and covariates (e.g., lapse, motivation, etc.) were modeled at level 1 and person mean centered. All models incorporated time between random EMAs as a covariate and centered time at four hours (consistent with average time between random EMAs per the study design) to account for effects of time between EMAs on lapse. All models covaried for factors that have been robustly linked to smoking cessation, namely age, partner status, education, gender, cigarettes per day, e-cigarette use, depression, and anxiety (Cosci et al., 2011; Kim et al., 2024; Manchón Walsh et al., 2007; Smith et al., 2016; Trinidad et al., 2011; Wetter et al., 2005), estimated random intercepts and utilized an unstructured covariance matrix. Participant characteristics were modeled at level 2 and grand mean centered.

Three models were estimated to test study hypotheses (Figure 1). Model 1 estimated the within-person association between lapse reported at time t (i.e., lapse in the interval between time t-1 and time t using random EMAs) with patch use at time t. Model 1 also covaried for patch use at time t-1. Models 2 and 3 estimated the association of the main predictors of interest (motivation, self-efficacy, urge, cigarette availability) with patch use, using a model building approach to determine the strength of the association between the predictor and outcome when covarying for additional proximal predictors of patch use. Specifically, Model 2 examined the within-person association of the predictor (e.g., motivation) reported at time t-1 on patch use reported at time t, covarying for patch use reported at time t-1 and lapse reported at time t (i.e., lapse in the interval between time t-1 and time 1). Model 3 builds on Model 2 by additionally covarying for the predictor (e.g., motivation) reported at time t. Models 2 and 3 were repeated for each predictor, and in addition to those listed above, included several other covariates (the between-person effect of the predictor – which was defined as the person-mean of the predictor – and lapse). Time between t-1 and t were limited to 16-hour timeframes, however, we varied this timeframe to be 4 hours, 8 hours, and without time constraints for sensitivity analyses.

Figure 1.

Figure 1

Schematic of models 1–3.

Note. Time t indicates current time, t-1 is 4 hours prior to time t, on average.

1.3. Results

Of the 302 enrolled participants, 268 provided at least one EMA pre- or post-quit. Only those who provided at least one post-quit EMA and had information on demographic data were retained in the present analyses (N=239). There were no significant differences in demographics (e.g., gender, income, age) or cigarettes per day between those who were retained verses those who were not, nor were there significant associations between these indices and EMA compliance. The analytic sample was 50% female, 72% were married or cohabitating, and 21% had a college degree. Participants ages ranged between 18–74 years of age (M=49.40, SD=12.26). Most participants reported a household income of less than $20,000/yr (64%), 24% reported $20,000-39,999, 14% reported $40,000 or higher. Participants reported smoking approximately 14 cigarettes per day (M=14.29, SD=7.54, range 3–48), and had been smoking for about 30 years (M=30.13, SD=13.46, range 0–60). On average, participants retained in the analytic sample responded to 2–3 random EMAs per day (~65% compliance). Participants responded to 77% of sensor-prompted EMAs, on average, and reported patch use on 76% of post-quit EMAs and lapses on 45% of post-quit EMAs.

1.3.1. Model 1: Patterns of Use

Patch use at t-1 was associated with a higher odds of patch use at the next EMA. In moments where a person wore the patch, they had 16 times greater odds of wearing the patch at the next EMA (OR=16.24, 95% CI: 11.92, 22.13). When a person lapsed in the interval between time t-1 and t, they had a 39% lower odds of patch use at time t (OR=0.61, 95% CI: 0.42, 0.88). Associations of patch use (at t-1) and lapse (in the interval t-1 to t) with patch use at time t remained significant in Models 2–3 below and are not described again.

1.3.2. Models 2–3: Influencing Factors

Motivation at time t-1 was not associated with patch use at time t (Model 2). Motivation at time t was associated with patch use at time t, such that when an individual’s motivation at time t was one unit higher than their own average, they had 28% greater odds of wearing the patch at time t (OR=1.28, 95% CI: 1.05, 1.55; Model 3).

Urge at time t-1 was not associated with patch use at time t (Model 2). Urge at time t was associated with patch use at time t, such that when an individual’s urge at time t was one unit higher than their own average, they had 23% lower odds of wearing the patch at time t (OR=0.77, 95% CI: 0.66, 0.89; Model 3).

Self-efficacy at time t-1 was not associated with patch use at time t (Model 2). Self-efficacy at time t was associated with patch use at time t, such that when an individual’s self-efficacy at time t was one unit higher than their own average, they had 31% greater odds of wearing the patch at time t (OR=1.31, 95% CI: 1.06, 1.62; Model 3).

Cigarette availability at time t-1 was not associated with patch use at time t (Model 2). Cigarette availability at time t was associated with patch use at time t, such that when an individual’s level of cigarette availability at time t was one unit higher than their own average, they had 16% lower odds of wearing the patch at time t (OR=0.84, 95% CI: 0.71, 0.99; Model 3).

Sensitivity Analyses tested whether results were consistent with no time limit, an 8-, and 4-hour time limit between lagged assessments. Results for models without a time limit between the lagged assessments were consistent with what is reported above in terms of directionality and significance with one exception. In Model 3, cigarette availability at time t was not significantly related to patch use. In models limiting time between EMA assessments to less than or equal to 8 hours, results were consistent in terms of directionality and significance for patch use at t-1, lapse at time t, and urge at time t predicting patch use at time t. However, associations for motivation at t, self-efficacy at t, and cigarette availability at t were not significant. In models limiting time between EMA assessments to less than or equal to 4 hours, patch use at t-1 and lapse at time t predicted patch use at time t. However, associations for motivation at t, self-efficacy at t, urge at t, and cigarette availability at t were not significant.

1.4. Discussion

The goal of the present study was to examine the real-time, real-world associations between a set of known risk factors and nicotine patch adherence in a sample of African Americans who smoke during a quit attempt. Although there were no significant lagged associations between our hypothesized primary predictors (motivation, urge, self-efficacy, and cigarette availability) and patch use, concurrent motivation and self-efficacy were related to greater odds of patch use in the concurrent time frame (i.e., when both measures were assessed at the same EMA prompt). Contrary to hypotheses, urge and cigarette availability were related to lower odds of patch use in the concurrent time frame. As predicted, lapse in the interval between t-1 and t was associated with lower odds of patch use a time t, and not surprisingly, patch use at one time point was highly predictive of patch use at the next time point. Altogether, we found robust concurrent associations among acute precipitants and NRT use, which is consistent with social cognitive and relapse prevention theories.

In line with previous research suggesting that relapse may be related to NRT non-adherence (Hughes, 2012; Pacek et al., 2018), we found that lapse in the interval between t-1 and t was associated with lower odds of patch use at time t. Because both lapse and NRT were reported at time t, it is impossible to tell whether individuals removed the patch before or after their lapse. For example, momentary lapse may lead to non-adherence (Burns & Levinson, 2008; Schlam et al., 2018), which may be consistent with the abstinence violation effect whereby a lapse results in feelings of failure such that individuals ‘give up’ and take the patch off. Individuals may also take off the patch before they lapse. Nicotine patch labels previously warned against smoking while wearing the patch, but this recommendation has since changed and the FDA now recommends that there is no need to remove the patch if you lapse. However, the negative association between lapse and NRT adherence could reflect participants taking off the patch before smoking in an attempt to avoid side effects of using both cigarettes and the patch (Burns & Levinson, 2008; Hughes, 2012).

The significant concurrent associations of motivation and self-efficacy with adherence is consistent with prior cross-sectional (Alterman et al., 1999; Kim et al., 2019) and experimental studies (Ojo-Fati et al., 2016). These results suggest that motivation and self-efficacy may be tied to decision making or goal setting regarding patch use and abstinence goals in the moment (Mersha et al., 2020), but not with predicting future patch adherence. The current findings may reflect that patch use leads to higher motivation and self-efficacy, that effects are moderated by contextual factors not investigated here, or that some aspect of our methodology (e.g., frequency of EMAs) may not reveal temporal associations between the variables under examination. Similarly, cigarette availability has been established as a robust proximal predictor of smoking lapse (Cambron et al., 2020), and recent work suggests that context is also predictive of NRT adherence (Mersha et al., 2020). The results of the current study support that having cigarettes available (whether through social contexts or cigarettes on the person/in the home) is associated with lower patch adherence.

Baseline stress-elicited urge has shown a positive association with daily patch use (assessed at 4 weeks post-quit via timeline follow-back) in prior work (Kim et al., 2019). In contrast to this between-person effect, our results suggest that urge was related to lower odds of patch use in proximal time frames. It could be that individuals take the patch off when they experience high urge because they believe the patch may not be effective, reducing their motivation to keep using the patch. This is in line with research showing that individuals are non-adherent to NRT because they do not believe that it will help them quit (Pacek et al., 2018), or because they may have unrealistic expectations about urges being completely eliminated while wearing the patch (Shadel et al., 2016). It could also be that individuals take the patch off when they have more urges in anticipation of smoking (Hughes, 2012; Pacek et al., 2018).

Prior evidence suggests that compared to White individuals using NRT (patch) for tobacco cessation, African Americans using the patch are less likely to achieve long-term abstinence (West et al., 2018) highlighting the need to understand factors that may impede cessation in African Americans attempting to quit. Given that limited research to-date has examined real-time, real-world factors that may act as barriers or facilitators to tobacco cessation among African Americans attempting to quit, the current results make a unique contribution to the literature on real-time variables that may contribute to tobacco cessation inequities in this group. Future studies testing racial differences in real-time factors that influence NRT is an important area for future research. These results should also be interpreted in the context of a recent study suggesting that the efficacy the patch may diminish over time in African Americans attempting to quit (Nollen et al., 2021), although the patch was more efficacious than placebo in the short-term in this study, which is in line with the time frame of assessment in the current work. Nonetheless, efficacy or beliefs about efficacy may impact adherence in this population (Carpenter et al., 2011).

The current results also have implications for interventions consistent with currently recommended treatment, given they generally attempt to boost motivation and self-efficacy and reduce cigarette availability and urges to smoke, all of which are associated with patch adherence. Alternatively, these results may suggest that treatments should focus more on promoting patch adherence to increase motivation and self-efficacy. Given that momentary levels of these predictors were associated with adherence, our results suggest that Just-in-Time Adaptive Interventions (JITAIs), which deliver the right type of support at the right time, may be appropriate (Nahum-Shani et al., 2018). That is, JITAIs may tailor the timing and/or type of intervention in near real-time and in the real world to boost patch adherence and abstinence. Future studies should also consider the impact of socioeconomic status on patch use and adherence. Although participants in the current study received patches for free, racial and ethnic minorities may be disproportionately represented in lower socioeconomic groups (Williams et al., 1997), which could influence the ability to use patches (or other forms of tobacco cessation treatment; especially among the uninsured).

This study had limitations. Participants received smoking cessation counseling as part of the study, however, it is unclear whether counseling would impact the within-person associations examined herein. Participants in this study were not provided with other forms of NRT (e.g., gum), which prevents investigation of adherence to combined therapy, nor was there data verify self-reported patch use. We also do not have information about whether any participant chose not to ever start wearing the patches they were offered at the first visit. The data also does not include information to investigate the possibility that compensation impacted compliance with EMAs. Although the current study examined within-person associations, these models do not imply causation. There is a body of evidence suggesting that higher NRT adherence-related self-efficacy and motivation may improve adherence to prescribed NRT (Pacek et al., 2018; Tseng et al., 2017). Although not assessed in the current study, NRT-related self-efficacy and motivation may be a promising area for future research. The sample was recruited using a range of methods to reach the general population. However, it is possible that the sample is not representative of all African Americans who smoke, as those who participated may differ from other smokers who are motivated to quit but did not participate.

1.4.2. Conclusions

The current study provides novel information about proximal predictors of NRT adherence and may elucidate specific factors influencing tobacco cessation among African Americans. This study suggests that interventions focusing on promoting patch adherence and/or leveraging the benefits of protective factors (e.g., motivation and self-efficacy) and of reduced risk factors (urge and cigarette availability) might improve patch adherence. The current study can inform future studies aiming to develop JITAIs for smoking cessation.

Table 1.

Results from Models 2 and 3, showing the odds ratio for motivation predicting nicotine patch use.

Model 2 Model 3

OR CI OR CI
Intercept 1.26 0.48 3.28 1.28 0.49 3.37
Motivation at T-1 1.04 0.85 1.27 1.03 0.84 1.26
Motivation at T -- -- -- 1.28* 1.05 1.55
Grand mean Motivation 1.35 0.95 1.93 1.37 0.95 1.96
Lapse at T 0.52* 0.36 0.74 0.51* 0.36 0.74
Grand mean Lapse 0.94 0.39 2.22 0.89 0.37 2.14
Patch at t-1 16.03* 011.77 21.82 16.42* 12.03 22.43
Age 1.03* 1.00 1.05 1.03* 1.01 1.05
Married/Cohabit 1.85* 1.05 3.26 1.85* 1.05 3.28
College Education 0.75 0.40 1.42 0.76 0.40 1.45
Male Gender 0.82 0.49 1.36 0.81 0.48 1.35
Depression 1.02 0.95 1.09 1.02 0.95 1.09
Anxiety 1.00 0.93 1.07 0.99 0.92 1.07
Nicotine Dependence 1.03* 1.00 1.06 1.03* 1.00 1.07
Time Difference in T and T-1 1.00 0.96 1.03 1.00 0.96 1.03
E-cigarette use 1.02 0.92 1.13 1.02 0.92 1.13

Note. OR=odds ratio; CI=confidence interval.

*

Indicates a significant effect where the confidence interval does not include 1.

Table 2.

Results from Models 2 and 3, showing the odds ratio for urge predicting nicotine patch use.

Model 2 Model 3

OR CI OR CI
Intercept 1.21 0.47 3.12 1.21 0.46 3.16
Urge at T-1 1.04 0.90 1.20 1.07 0.92 1.24
Urge at T -- -- -- 0.77* 0.66 0.89
Grand mean Urge 0.81 0.59 1.10 0.79 0.58 1.08
Lapse at T 0.51* 0.36 0.73 0.53* 0.37 0.76
Grand mean Lapse 0.98 0.41 2.37 0.91 0.37 2.22
Patch at t-1 16.44* 12.05 22.43 16.84* 12.30 23.06
Age 1.03* 1.01 1.05 1.03* 1.01 1.05
Married/Cohabit 1.79* 1.02 3.14 1.79* 1.01 3.17
College Education 0.73 0.39 1.37 0.74 0.39 1.41
Male Gender 0.84 0.51 1.39 0.84 0.50 1.40
Depression 1.02 0.95 1.09 1.03 0.96 1.10
Anxiety 0.99 0.93 1.07 0.99 0.92 1.06
Nicotine Dependence 1.03* 1.00 1.07 1.03* 1.00 1.07
Time Difference in T and T-1 1.00 0.96 1.03 0.99 0.96 1.03
E-cigarette use 1.02 0.92 1.12 1.01 0.92 1.12

Note. OR=odds ratio; CI=confidence interval.

*

Indicates a significant effect where the confidence interval does not include 1.

Table 3.

Results from Models 2 and 3, showing the odds ratio for self-efficacy predicting nicotine patch use.

Model 2 Model 3

OR CI OR CI
Intercept 1.25 0.48 3.27 1.26 0.48 3.31
Self-Efficacy at T-1 1.04 0.84 1.29 1.04 0.84 1.29
Self-Efficacy at T -- -- -- 1.31* 1.06 1.62
Grand mean Self-Efficacy 1.22 0.86 1.72 1.23 0.86 1.75
Lapse at T 0.52* 0.36 0.74 0.52* 0.36 0.74
Grand mean Lapse 0.89 0.38 2.11 0.84 0.35 2.02
Patch at t-1 16.08* 11.80 21.90 16.27* 11.91 22.22
Age 1.03* 1.01 1.05 1.03* 1.01 1.05
Married/Cohabit 1.84* 1.04 3.24 1.85* 1.04 3.29
College Education 0.76 0.40 1.43 0.77 0.40 1.46
Male Gender 0.81 0.49 1.35 0.80 0.47 1.34
Depression 1.02 0.95 1.09 1.02 0.95 1.09
Anxiety 1.00 0.93 1.07 0.99 0.92 1.07
Nicotine Dependence 1.03* 1.00 1.06 1.03* 1.00 1.07
Time Difference in T and T-1 1.00 0.96 1.03 1.00 0.96 1.03
E-cigarette use 1.02 0.92 1.13 1.02 0.92 1.12

Note. OR=odds ratio; CI=confidence interval.

*

Indicates a significant effect where the confidence interval does not include 1.

Table 4.

Results from Models 2 and 3, showing the odds ratio for cigarette availability predicting nicotine patch use.

Model 2 Model 3

OR CI OR CI
Intercept 1.24 0.48 3.25 1.27 0.48 3.34
Cigarette Availability at T-1 0.97 0.84 1.12 1.01 0.87 1.17
Cigarette Availability at T -- -- -- 0.84* 0.71 0.99
Grand mean Cigarette Availability 1.02 0.80 1.28 1.02 0.80 1.29
Lapse at T 0.52* 0.36 0.74 0.54* 0.37 0.77
Grand mean Lapse 0.80 0.33 1.93 0.75 0.31 1.82
Patch at t-1 16.18* 11.89 22.03 16.38* 12.01 22.35
Age 1.03* 1.01 1.05 1.03* 1.01 1.05
Married/Cohabit 1.82* 1.03 3.21 1.83* 1.03 3.24
College Education 0.74 0.39 1.39 0.75 0.39 1.42
Male Gender 0.82 0.49 1.36 0.80 0.48 1.34
Depression 1.02 0.95 1.09 1.02 0.96 1.10
Anxiety 1.00 0.93 1.07 0.99 0.92 1.06
Nicotine Dependence 1.03* 1.00 1.06 1.03* 1.00 1.07
Time Difference in T and T-1 1.00 0.96 1.03 1.00 0.96 1.03
E-cigarette use 1.02 0.92 1.13 1.02 0.92 1.13

Note. OR=odds ratio; CI=confidence interval.

*

Indicates a significant effect where the confidence interval does not include 1.

Highlights.

  • Lapse, urge, and cigarette availability were negatively associated with adherence

  • Motivation and self-efficacy were positively associated with adherence

  • Predictors of adherence may inform interventions for African Americans who smoke

Role of Funding Source

Research reported in this publication was supported by awards from the National Institute on Minority Health and Health Disparities (R01MD010362), National Cancer Institute (P30CA042014; K99CA252604-01A1; U01CA229437), the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR002538), the National Institute on Drug Abuse (P50DA054039; R01DA039901) and the Huntsman Cancer Foundation. R01MD010362 support data collection and all other sources support analysis, interpretation, and manuscript writing.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Declaration of Interest: None

Conflict of Interest: No conflict declared

References

  1. Adler NE, & Ostrove JM (1999). Socioeconomic status and health: what we know and what we don’t. Annals of the New York Academy of Sciences, 896(1), 3–15. [DOI] [PubMed] [Google Scholar]
  2. Alterman AI, Gariti P, Cook TG, & Cnaan A (1999). Nicodermal patch adherence and its correlates. Drug Alcohol Depend, 53(2), 159–165. 10.1016/s0376-8716(98)00124-0 [DOI] [PubMed] [Google Scholar]
  3. Brandon TH, Vidrine JI, & Litvin EB (2007). Relapse and relapse prevention. Annual Review of Clinical Psychology, 3, 257–284. 10.1146/annurev.clinpsy.3.022806.091455 [DOI] [PubMed] [Google Scholar]
  4. Burns EK, & Levinson AH (2008). Discontinuation of nicotine replacement therapy among smoking-cessation attempters. Am J Prev Med, 34(3), 212–215. 10.1016/j.amepre.2007.11.010 [DOI] [PubMed] [Google Scholar]
  5. Businelle MS, Kendzor DE, Reitzel LR, Costello TJ, Cofta-Woerpel L, Li Y, Mazas CA, Vidrine JI, Cinciripini PM, Greisinger AJ, & Wetter DW (2010). Mechanisms linking socioeconomic status to smoking cessation: a structural equation modeling approach. Health Psychol, 29(3), 262–273. 10.1037/a0019285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cambron C, Haslam AK, Baucom BRW, Lam C, Vinci C, Cinciripini P, Li L, & Wetter DW (2019). Momentary precipitants connecting stress and smoking lapse during a quit attempt. Health Psychology, 38, 1049–1058. 10.1037/hea0000797 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cambron C, Lam CY, Cinciripini P, Li L, & Wetter DW (2020). Socioeconomic Status, Social Context, and Smoking Lapse During a Quit Attempt: An Ecological Momentary Assessment Study. Annals of Behavioral Medicine, 54(3), 141–150. 10.1093/abm/kaz034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carpenter MJ, Ford ME, Cartmell K, & Alberg AJ (2011). Misperceptions of nicotine replacement therapy within racially and ethnically diverse smokers. J Natl Med Assoc, 103(9–10), 885–894. 10.1016/s0027-9684(15)30444-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Collins SE, Eck S, Torchalla I, Schröter M, & Batra A (2013). Understanding treatment-seeking smokers’ motivation to change: content analysis of the decisional balance worksheet. Addict Behav, 38(1), 1472–1480. 10.1016/j.addbeh.2012.08.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cornelius ME, Loretan CG, Jamal A, Davis Lynn BC, Mayer M, Alcantara IC, & Neff L (2023). Tobacco Product Use Among Adults - United States, 2021. MMWR Morb Mortal Wkly Rep, 72(18), 475–483. 10.15585/mmwr.mm7218a1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cornelius ME, Loretan CG, Wang TW, Jamal A, & Homa DM (2022). Tobacco Product Use Among Adults - United States, 2020. In MMWR Morb Mortal Wkly Rep (Vol. 71, pp. 397–405). 10.15585/mmwr.mm7111a1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cosci F, Pistelli F, Lazzarini N, & Carrozzi L (2011). Nicotine dependence and psychological distress: outcomes and clinical implications in smoking cessation. Psychol Res Behav Manag, 4, 119–128. 10.2147/prbm.S14243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Creamer MR, Wang TW, Babb S, Cullen KA, Day H, Willis G, Jamal A, & Neff L (2019). Tobacco Product Use and Cessation Indicators Among Adults - United States, 2018. Mmwr-Morbidity and Mortality Weekly Report, 68(45), 1013–1019. 10.15585/mmwr.mm6845a2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Crittenden KS, Manfredi C, Cho YI, & Dolecek TA (2007). Smoking cessation processes in low-SES women: the impact of time-varying pregnancy status, health care messages, stress, and health concerns. Addictive behaviors, 32(7), 1347–1366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJL, & Ezzati M (2009). The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors. Plos Medicine, 6(4), Article e1000058. 10.1371/journal.pmed.1000058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ertin E, Stohs N, Kumar S, Raij A, Al’Absi M, & Shah S (2011). AutoSense: Unobtrusively wearable sensor suite for inferring the onset, causality, and consequences of stress in the field. ACM Conference on Embedded Networked Sensor Systems, [Google Scholar]
  17. Fagerström KO, Schneider NG, & Lunell E (1993). Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology (Berl), 111(3), 271–277. 10.1007/bf02244941 [DOI] [PubMed] [Google Scholar]
  18. Ferguson SG, & Shiffman S (2009). The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abuse Treat, 36(3), 235–243. 10.1016/j.jsat.2008.06.005 [DOI] [PubMed] [Google Scholar]
  19. Ferguson SG, Shiffman S, & Gwaltney CJ (2006). Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial. J Consult Clin Psychol, 74(6), 1153–1161. 10.1037/0022-006x.74.6.1153 [DOI] [PubMed] [Google Scholar]
  20. Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, Henderson PN, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Mullen PD, Orleans CT, . . . Staff PHSGU. (2008). Treating tobacco use and dependence: 2008 update US Public Health Service Clinical Practice Guideline executive summary. Respiratory Care, 53(9), 1217–1222. <Go to ISI>://WOS:000259153500011 [PubMed] [Google Scholar]
  21. Fu SS, Kodl MM, Joseph AM, Hatsukami DK, Johnson EO, Breslau N, Wu B, & Bierut L (2008). Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years. Cancer Epidemiol Biomarkers Prev, 17(7), 1640–1647. 10.1158/1055-9965.Epi-07-2726 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, & Le Marchand L (2006). Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med, 354(4), 333–342. 10.1056/NEJMoa033250 [DOI] [PubMed] [Google Scholar]
  23. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, & Lancaster T (2018). Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev, 5(5), Cd000146. 10.1002/14651858.CD000146.pub5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hébert ET, Bhushan T, Ra CK, Frank-Pearce S, Alexander AC, Cole AB, Kendzor DE, & Businelle MS (2021). Daily use of nicotine replacement medications is related to daily smoking status: An ecological momentary assessment study. Drug Alcohol Depend, 229(Pt A), 109161. 10.1016/j.drugalcdep.2021.109161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Holford TR, Levy DT, & Meza R (2016). Comparison of Smoking History Patterns Among African American and White Cohorts in the United States Born 1890 to 1990. Nicotine Tob Res, 18 Suppl 1(Suppl 1), S16–29. 10.1093/ntr/ntv274 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hughes JR (2012). Use of nicotine replacement after a smoking lapse. Nicotine Tob Res, 14(6), 751–754. 10.1093/ntr/ntr208 [DOI] [PubMed] [Google Scholar]
  27. Hughes JR, Shiffman S, Callas P, & Zhang J (2003). A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control, 12(1), 21–27. 10.1136/tc.12.1.21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kim SS, Prasad A, Nayak MM, Chen H, Srisoem C, DeMarco RF, Castaldi P, & Cooley ME (2024). Predictors of Nicotine Replacement Therapy Adherence: Mixed-Methods Research With a Convergent Parallel Design. Ann Behav Med, 58(4), 275–285. 10.1093/abm/kaae006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kulak JA, Cornelius ME, Fong GT, & Giovino GA (2016). Differences in Quit Attempts and Cigarette Smoking Abstinence Between Whites and African Americans in the United States: Literature Review and Results From the International Tobacco Control US Survey. Nicotine Tob Res, 18 Suppl 1(Suppl 1), S79–87. 10.1093/ntr/ntv228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kushnir V, Sproule BA, & Cunningham JA (2017). Mailed distribution of free nicotine patches without behavioral support: Predictors of use and cessation. Addict Behav, 67, 73–78. 10.1016/j.addbeh.2016.12.008 [DOI] [PubMed] [Google Scholar]
  31. Manchón Walsh P, Carrillo P, Flores G, Masuet C, Morchon S, & Ramon JM (2007). Effects of partner smoking status and gender on long term abstinence rates of patients receiving smoking cessation treatment. Addict Behav, 32(1), 128–136. 10.1016/j.addbeh.2006.03.027 [DOI] [PubMed] [Google Scholar]
  32. Mersha AG, Gould GS, Bovill M, & Eftekhari P (2020). Barriers and Facilitators of Adherence to Nicotine Replacement Therapy: A Systematic Review and Analysis Using the Capability, Opportunity, Motivation, and Behaviour (COM-B) Model. Int J Environ Res Public Health, 17(23). 10.3390/ijerph17238895 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mokdad AH, Marks JS, Stroup DF, & Gerberding JL (2004). Actual causes of death in the United States, 2000 [Article]. Jama-Journal of the American Medical Association, 291(10), 1238–1245. 10.1001/jama.291.10.1238 [DOI] [PubMed] [Google Scholar]
  34. Nahum-Shani I, Smith SN, Spring BJ, Collins LM, Witkiewitz K, Tewari A, & Murphy SA (2018). Just-in-Time Adaptive Interventions (JITAIs) in Mobile Health: Key Components and Design Principles for Ongoing Health Behavior Support [Article]. Annals of Behavioral Medicine, 52(6), 446–462. 10.1007/s12160-016-9830-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Nakajima M, Lemieux AM, Fiecas M, Chatterjee S, Sarker H, Saleheen N, Ertin E, Kumar S, & al ‘Absi M (2020). Using novel mobile sensors to assess stress and smoking lapse. International Journal of Psychophysiology, 158, 411–418. 10.1016/j.ijpsycho.2020.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nollen N, Ahluwalia JS, Mayo MS, Richter K, Choi WS, Okuyemi KS, & Resnicow K (2007). A randomized trial of targeted educational materials for smoking cessation in African Americans using transdermal nicotine. Health Educ Behav, 34(6), 911–927. 10.1177/1090198106294652 [DOI] [PubMed] [Google Scholar]
  37. Nollen NL, Ahluwalia JS, Sanderson Cox L, Okuyemi K, Lawrence D, Samuels L, & Benowitz NL (2021). Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial. JAMA Netw Open, 4(1), e2032053. 10.1001/jamanetworkopen.2020.32053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ojo-Fati O, Thomas JL, Vogel RI, Ogedegbe O, Jean-Louis G, & Okuyemi KS (2016). Predictors of Adherence to Nicotine Replacement Therapy (Nicotine Patch) Among Homeless Persons Enrolled in a Randomized Controlled Trial Targeting Smoking Cessation. J Fam Med, 3(7). [PMC free article] [PubMed] [Google Scholar]
  39. Okuyemi KS, Zheng H, Guo H, & Ahluwalia JS (2010). Predictors of adherence to nicotine gum and counseling among African-American light smokers. J Gen Intern Med, 25(9), 969–976. 10.1007/s11606-010-1386-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Pacek LR, McClernon FJ, & Bosworth HB (2018). Adherence to Pharmacological Smoking Cessation Interventions: A Literature Review and Synthesis of Correlates and Barriers. Nicotine Tob Res, 20(10), 1163–1172. 10.1093/ntr/ntx210 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Potter LN, Yap J, Dempsey W, Wetter DW, & Nahum-Shani I (2023). Integrating Intensive Longitudinal Data (ILD) to Inform the Development of Dynamic Theories of Behavior Change and Intervention Design: a Case Study of Scientific and Practical Considerations. Prev Sci 10.1007/s11121-023-01495-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sakuma KK, Felicitas-Perkins JQ, Blanco L, Fagan P, Pérez-Stable EJ, Pulvers K, Romero D, & Trinidad DR (2016). Tobacco use disparities by racial/ethnic groups: California compared to the United States. Prev Med, 91, 224–232. 10.1016/j.ypmed.2016.08.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Saleheen N, Ali AA, Hossain SM, Sarker H, Chatterjee S, Marlin B, Ertin E, al’Absi M, & Kumar S (2015). puffMarker: A multi-sensor approach for pinpointing the timing of first lapse in smoking cessation. Proc ACM Int Conf Ubiquitous Comput, 2015, 999–1010. https://www.ncbi.nlm.nih.gov/pubmed/26543927 [PMC free article] [PubMed] [Google Scholar]
  44. Schlam TR, Cook JW, Baker TB, Hayes-Birchler T, Bolt DM, Smith SS, Fiore MC, & Piper ME (2018). Can we increase smokers’ adherence to nicotine replacement therapy and does this help them quit? Psychopharmacology (Berl), 235(7), 2065–2075. 10.1007/s00213-018-4903-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Shadel WG, Galvan FH, & Tucker JS (2016). Developing a nicotine patch adherence intervention for HIV-positive Latino smokers. Addict Behav, 59, 52–57. 10.1016/j.addbeh.2016.03.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Shiffman S, Sweeney CT, Ferguson SG, Sembower MA, & Gitchell JG (2008). Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Clin Ther, 30(10), 1852–1858. 10.1016/j.clinthera.2008.09.016 [DOI] [PubMed] [Google Scholar]
  47. Siegel RL, Miller KD, Fuchs HE, & Jemal A (2022). Cancer statistics, 2022. CA Cancer J Clin, 72(1), 7–33. 10.3322/caac.21708 [DOI] [PubMed] [Google Scholar]
  48. Smith PH, Bessette AJ, Weinberger AH, Sheffer CE, & McKee SA (2016). Sex/gender differences in smoking cessation: A review. Prev Med, 92, 135–140. 10.1016/j.ypmed.2016.07.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Stahre M, Okuyemi KS, Joseph AM, & Fu SS (2010). Racial/ethnic differences in menthol cigarette smoking, population quit ratios and utilization of evidence-based tobacco cessation treatments. Addiction, 105 Suppl 1, 75–83. 10.1111/j.1360-0443.2010.03200.x [DOI] [PubMed] [Google Scholar]
  50. Stanton CA, Lloyd-Richardson EE, Papandonatos GD, de Dios MA, & Niaura R (2009). Mediators of the relationship between nicotine replacement therapy and smoking abstinence among people living with HIV/AIDS. AIDS Educ Prev, 21(3 Suppl), 65–80. 10.1521/aeap.2009.21.3_supp.65 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Trinidad DR, Pérez-Stable EJ, White MM, Emery SL, & Messer K (2011). A nationwide analysis of US racial/ethnic disparities in smoking behaviors, smoking cessation, and cessation-related factors. Am J Public Health, 101(4), 699–706. 10.2105/ajph.2010.191668 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Tseng TY, Krebs P, Schoenthaler A, Wong S, Sherman S, Gonzalez M, Urbina A, Cleland CM, & Shelley D (2017). Combining Text Messaging and Telephone Counseling to Increase Varenicline Adherence and Smoking Abstinence Among Cigarette Smokers Living with HIV: A Randomized Controlled Study. AIDS Behav, 21(7), 1964–1974. 10.1007/s10461-016-1538-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. VanFrank B, Marlarcher A, Cornelius ME, Schecter A, Jamal A, & Tynan M (2024). Adult Smoking Cessation—United States, 2022. MMWR. Morbidity and Mortality Weekly Report, 73(29), 633–641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. West R, Evins AE, Benowitz NL, Russ C, McRae T, Lawrence D, St Aubin L, Krishen A, Maravic MC, & Anthenelli RM (2018). Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES. Addiction, 113(8), 1507–1516. 10.1111/add.14208 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wetter DW, Cofta-Gunn L, Irvin JE, Fouladi RT, Wright K, Daza P, Mazas C, Cinciripini PM, & Gritz ER (2005). What accounts for the association of education and smoking cessation? Prev Med, 40(4), 452–460. 10.1016/j.ypmed.2004.07.001 [DOI] [PubMed] [Google Scholar]
  56. Wiggers LC, Smets EM, Oort FJ, Storm-Versloot MN, Vermeulen H, van Loenen LB, Peters RJ, de Haes HC, & Legemate DA (2006). Adherence to nicotine replacement patch therapy in cardiovascular patients. Int J Behav Med, 13(1), 79–88. 10.1207/s15327558ijbm1301_10 [DOI] [PubMed] [Google Scholar]
  57. Williams DR, Yan Y, Jackson JS, & Anderson NB (1997). Racial differences in physical and mental health: Socio-economic status, stress and discrimination. J Health Psychol, 2(3), 335–351. 10.1177/135910539700200305 [DOI] [PubMed] [Google Scholar]
  58. Witkiewitz K, & Marlatt GA (2004). Relapse prevention for alcohol and drug problems - That was Zen, this is Tao. American Psychologist, 59(4), 224–235. 10.1037/0003-066x.59.4.224 [DOI] [PubMed] [Google Scholar]
  59. Yingst JM, Veldheer S, Hrabovsky S, Sciamanna C, & Foulds J (2015). Reasons for non-adherence to nicotine patch therapy during the first month of a quit attempt. Int J Clin Pract, 69(8), 883–888. 10.1111/ijcp.12644 [DOI] [PubMed] [Google Scholar]

RESOURCES